Theriva Biologics (TOVX) Change in Cash (2010 - 2026)
Theriva Biologics (TOVX) posted quarterly Change in Cash of $1.4 million for Q1 2026, up 186.36% year-over-year from $479814.3 in Q1 2025, and down 75.14% quarter-over-quarter from $5.5 million in Q4 2025.
Theriva Biologics (TOVX) Change in Cash (2010 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported Change in Cash for 17 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 186.36% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $4.4 million (up 152.9% YoY), while the FY2025 annual figure was $1.4 million, up 112.07% from the prior year.
- Change in Cash slipped to $1.4 million in Q1 2026 per TOVX's latest filing, from $5.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $5.5 million in Q4 2025 and bottomed at -$10.5 million in Q1 2022.
- Historically, Change in Cash has averaged -$3.1 million across 5 years, with a median of -$3.1 million in 2023.
- On a YoY basis, Change in Cash climbed as much as 223.02% in 2025 and fell as far as 2451.11% in 2025.
- Theriva Biologics' Change in Cash stood at -$8.7 million in 2022, then advanced by 7.91% to -$8.0 million in 2023, then surged by 39.75% to -$4.8 million in 2024, then soared by 215.0% to $5.5 million in 2025, then slumped by 75.14% to $1.4 million in 2026.
- Business Quant data shows TOVX's Change in Cash at $1.4 million in Q1 2026, $5.5 million in Q4 2025, and -$4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - | -3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.10 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 5.53 Mn |
| Sep 30, 2025 | -4.59 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | -1.59 Mn |
| Dec 31, 2024 | -4.81 Mn |
| Sep 30, 2024 | -180,000.00 |
| Jun 30, 2024 | -1.67 Mn |
| Mar 31, 2024 | -4.92 Mn |
| Dec 31, 2023 | -7.98 Mn |
| Sep 30, 2023 | -3.09 Mn |
| Jun 30, 2023 | -1.83 Mn |
| Mar 31, 2023 | -5.71 Mn |
| Dec 31, 2022 | -8.66 Mn |
| Sep 30, 2022 | -1.78 Mn |
| Jun 30, 2022 | -4.43 Mn |
| Mar 31, 2022 | -10.53 Mn |
| Dec 31, 2021 | -4.81 Mn |
| Sep 30, 2021 | -2.16 Mn |